Status:
COMPLETED
Medication Adherence in Psoriatic Arthritis
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Psoriatic arthritis (PsA) is a chronic multisystemic disease requiring ordinary doctor visits and an adherence to medication. Evaluating the parameters affecting the medication adherence is essential ...
Detailed Description
Psoriatic arthritis (PsA) is a multisystemic disease requiring ordinary doctor visits and an adherence to medication. Due to its chronic nature treatment regimens lasts for the lifetime and that may a...
Eligibility Criteria
Inclusion
- Diagnosed with PsA according to CASPAR criteria
- Administering PsA medication for at least 6 moths
- Aged ≥18
Exclusion
- Not having enough cognitive functions to understand and answer the questionnaires
- Having a psychiatric disorder
- Having a severe comorbidity (e.g. malignancy, stroke)
Key Trial Info
Start Date :
February 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05223062
Start Date
February 18 2022
End Date
August 15 2022
Last Update
August 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University
Istanbul, Fatih, Turkey (Türkiye), 34093